| |
Bangalore, India, and New York City, USA; September 2, 2008
"MAPE Capital and Ferghana Partners Sign a Strategic Partnership Agreement"
Press release, October 10, 2005
"Ferghana and Gargoyle announce merger to create leading Investment Banking
Group focused on Healthcare and Chemicals Sectors"
Wall Street Reporter Magazine, June 23, 2004
"Transforming the Econimics of Pharmaceutical Research"
Nature Biotechnology, May 27, 2003
"The Money Men"
Stem Cell Business News, May 2, 2003
"Stem Cell Sector Needs a Viable Product to Spark Investor Interest"
BioWorld Today, March 12, 2003
"European Sector Rallying Cry: Comeback, Consolidation"
FPG Press Release, June 6, 2002
"Ferghana Partners Advised Schering AG on Refludan Transaction with Pharmion"
2nd Annual BIO European CEO & Investor Conference, 2001
SCRIP World Pharmaceutical News, November 28, 2001
"Lack of IPO Money now driving alliances"
Reuters, Nov 12, 2001
"Venture capitalists plough $1 Billion into Euro Biotech"
BioPartnering Europe 2001, October 23, 2001
"Ninth Annual Conference (Part VII) Report"
BioPartnering Europe 2001, October 19, 2001
"Ninth Annual Conference (Part IV) Report"
BioPartnering Europe (BPE), October 9, 2001
"Leading lifescience conference announces full event program"
Chemical Marker Reporter, October 8, 2001
"SCHERING AG; acquired rights for Refludan"
FPG release, October 2, 2001
"Ferghana Partners Group Completes Diversiture Assignment for Aventis"
Financial Times, February 15, 2001
"Testing Times for the Pharmaceuticals Industry"
FT Marketwatch, November 13, 2000
"Are biotechs a bubble about to burst?"
|
|
